MBIO
Mustang Bio, Inc. NASDAQ Listed Aug 22, 2017$0.57
After hrs
$0.57
-0.70%
Mkt Cap $4.3M
52w Low $0.53
3.7% of range
52w High $1.85
50d MA $0.65
200d MA $0.87
P/E (TTM)
—
EV/EBITDA
—
P/B
3.0x
Debt/Equity
0.0x
ROE
-20.2%
P/FCF
-5.3x
RSI (14)
47.20
ATR (14)
$0.04
Beta
2.18
50d MA
$0.65
200d MA
$0.87
Avg Volume
34.7K
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors. The company develops MB-107 and MB-207, a gene therapy program for X-linked severe combined immunodeficiency, a rare genetic immune system condition in which affected patients do not live beyond infancy without treatment. The company also develops MB-102 CAR T therapies for blastic plasmacytoid dendritic cell neoplasm, acute myeloid leukemia, and myelodysplastic syndrome; MB-106 CAR T cell program for B cell non-hodgkin lymphoma and chronic lymphocytic leukemia; MB-104 CAR T for multiple myeloma and light chain amyloidosis; MB-101 CAR T cell program for glioblastoma; MB-103 CAR T for glioblastoma multiforme (GBM) and metastatic breast cancer to brain; MB-105 CAR T for prostate and pancreatic cancers; and MB-108, a next-generation oncolytic herpes simplex virus. It has license agreements with Nationwide Children's Hospital, CSL Behring; Mayo Clin Mayo Clinic; Leiden University Medical Centre; SIRION Biotech GmbH, and Minaris Regenerative Medicine GmbH. The company was incorporated in 2015 and is headquartered in Worcester, Massachusetts.
377 Plantation Street · Worcester, MA 01605 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 2026 | AMC | -140.00 | -0.16 | +99.9% | 0.60 | -11.1% | -3.6% | +4.4% | -1.8% | +3.0% | -0.4% | — |
| May 5, 2026 | AMC | -140.00 | -0.14 | +99.9% | 0.77 | -3.1% | -3.6% | -2.6% | -4.3% | -5.2% | -0.3% | — |
| Mar 19, 2026 | AMC | -5.50 | -0.08 | +98.5% | 0.85 | -2.7% | -0.3% | -4.1% | -0.5% | -5.4% | -3.3% | — |
| Nov 7, 2025 | AMC | — | -0.07 | — | 1.22 | +9.0% | +0.8% | +0.8% | +0.8% | -3.2% | +0.8% | — |
| Aug 8, 2025 | AMC | — | -0.19 | — | 1.66 | -4.2% | +6.0% | -3.4% | +10.0% | -4.8% | -0.6% | — |
| May 14, 2025 | AMC | — | -0.05 | — | 1.12 | +0.0% | +0.9% | -0.9% | +3.6% | +6.9% | -4.0% | — |
| Mar 24, 2025 | AMC | -5.50 | -37.95 | -590.0% | 1.41 | +1.4% | +0.7% | -0.7% | +0.7% | -6.3% | -6.0% | — |
| Nov 8, 2024 | AMC | -6.50 | -2.00 | +69.2% | 12.75 | +0.0% | +0.8% | -0.6% | -4.9% | -3.0% | -3.1% | — |
| Aug 13, 2024 | AMC | -7.00 | -12.00 | -71.4% | 17.77 | -7.1% | -7.1% | +13.8% | -1.7% | +4.6% | -2.4% | — |
| May 15, 2024 | AMC | -0.87 | -23.00 | -2543.7% | 13.83 | -3.8% | +8.5% | +3.9% | +7.4% | -7.5% | -22.6% | — |
| Mar 11, 2024 | AMC | -84.00 | -35.50 | +57.7% | 58.00 | -1.7% | -8.6% | -8.6% | +2.7% | -4.5% | +9.5% | — |
| Nov 14, 2023 | AMC | -94.00 | -61.50 | +34.6% | 77.75 | +1.6% | +2.9% | -1.2% | +3.2% | +3.1% | -8.9% | — |
| Aug 14, 2023 | AMC | -103.50 | -100.00 | +3.4% | 201.50 | +0.0% | -5.7% | -4.2% | -10.4% | -1.2% | -5.0% | — |
| May 12, 2023 | AMC | -142.50 | -103.00 | +27.7% | 233.00 | +0.6% | -6.7% | -0.2% | +1.6% | -4.5% | -3.8% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 16 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $13.83 | $13.30 | -3.8% | +8.5% | +3.9% | +7.4% | -7.5% | -22.6% |
| May 13 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $13.00 | $13.52 | +4.0% | +0.0% | +3.3% | +3.0% | +8.5% | +3.9% |
| Aug 24 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $152.50 | $151.00 | -1.0% | -1.6% | -2.3% | +5.5% | +4.5% | +2.2% |
| Aug 16 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $190.00 | $200.50 | +5.5% | -4.2% | -10.4% | -1.2% | -5.0% | -1.3% |
| Aug 15 | BTIG | Maintains | Buy → Buy | — | $201.50 | $201.50 | +0.0% | -5.7% | -4.2% | -10.4% | -1.2% | -5.0% |
| Aug 15 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $201.50 | $201.50 | +0.0% | -5.7% | -4.2% | -10.4% | -1.2% | -5.0% |
| Jun 16 | BTIG | Maintains | Buy → Buy | — | $365.50 | $374.00 | +2.3% | +9.4% | -10.5% | -0.6% | -3.1% | +8.7% |
| Jun 16 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $365.50 | $374.00 | +2.3% | +9.4% | -10.5% | -0.6% | -3.1% | +8.7% |
| May 15 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $233.00 | $234.50 | +0.6% | -6.7% | -0.2% | +1.6% | -4.5% | -3.8% |
| Nov 16 | BTIG | Maintains | Buy → Buy | — | $358.95 | $367.50 | +2.4% | +8.7% | -0.1% | +0.6% | -4.2% | -1.1% |
| Jan 24 | B. Riley Securities | Maintains | Buy → Buy | — | $975.00 | $922.50 | -5.4% | +0.0% | -6.2% | -4.1% | -8.5% | +1.9% |
| May 18 | BTIG | Maintains | Buy → Buy | — | $2145.00 | $2257.50 | +5.2% | +10.8% | -1.3% | +3.8% | +0.6% | -1.8% |
| Oct 2 | B. Riley Securities | Maintains | Buy → Buy | — | $2370.00 | $2362.50 | -0.3% | +0.6% | +2.8% | +0.0% | +2.8% | +5.1% |
| Oct 2 | B. Riley FBR | Maintains | Buy → Buy | — | $2370.00 | $2362.50 | -0.3% | +0.6% | +2.8% | +0.0% | +2.8% | +5.1% |
| May 12 | Oppenheimer | Maintains | Outperform → Outperform | — | $2392.50 | $2505.00 | +4.7% | -7.5% | -1.4% | -3.4% | -2.5% | +2.6% |
| Aug 13 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2167.50 | $2362.50 | +9.0% | +22.8% | +5.1% | -1.1% | +5.4% | +6.4% |
| Aug 13 | H.C. Wainwright | Maintains | Buy → Buy | — | $2167.50 | $2362.50 | +9.0% | +22.8% | +5.1% | -1.1% | +5.4% | +6.4% |
| Jun 21 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $2527.50 | $2715.00 | +7.4% | +19.3% | -11.9% | -3.1% | +3.8% | -1.4% |
| Dec 21 | Oppenheimer | Maintains | Outperform → Outperform | — | $8197.50 | $8332.50 | +1.6% | +4.7% | +3.1% | -0.3% | -2.3% | +2.5% |
No insider trades available.
Institutional (13F) — Top 17
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Kestra Advisory Services, Llc | 196,991 | $138K | New | Jun 2026 |
| 2 | Blackrock, Inc. | 84,745 | $59K | New | Jun 2026 |
| 3 | Citadel Advisors Llc | 59,459 | $42K | Added | Jun 2026 |
| 4 | Cfo4life Group, Llc | 33,510 | $24K | New | Jun 2026 |
| 5 | Vanguard Capital Management Llc | 25,704 | $18K | — | Jun 2026 |
| 6 | Jane Street Group, Llc | 14,126 | $14K | New | Dec 2025 |
| 7 | Ubs Group Ag | 3,659 | $3K | Added | Mar 2026 |
| 8 | Sbi Securities Co., Ltd. | 509 | $357 | New | Jun 2026 |
| 9 | Morgan Stanley | 306 | $300 | Reduced | Dec 2025 |
| 10 | Virtu Financial Llc | 14,356 | $10 | New | Jun 2026 |
| 11 | Cullen/frost Bankers, Inc. | 13 | $9 | — | Mar 2026 |
| 12 | Bnp Paribas Financial Markets | 6 | $4 | — | Mar 2026 |
| 13 | Lanark Financial, Inc. | 3 | $2 | — | Jun 2026 |
| 14 | Jpmorgan Chase & Co | 2 | $1 | — | Mar 2026 |
| 15 | Cwm, Llc | 2 | $1 | — | Mar 2026 |
| 16 | Danske Bank A/s | 2 | $1 | — | Jun 2026 |
| 17 | Group One Trading Llc | 1 | $1 | New | Jun 2026 |
Mutual Funds / ETFs (N-PORT) — Top 3
All ↗
| # | Fund | Shares | Value | Period |
|---|---|---|---|---|
| 1 | Fidelity Extended Market Index Fund | 30,943 | $31K | Feb 2026 |
| 2 | Fidelity Series Total Market Index Fund | 4,184 | $3K | May 2026 |
| 3 | Fidelity Total Market Index Fund | 1,077 | $722 | May 2026 |
Valuation
Market Cap
$4.3M
Enterprise Value
$10.7M
P/E (TTM)
—
Forward P/E
—
PEG Ratio
0.30x
P/B
2.96x
P/S
—
P/FCF
-5.31x
EV/EBITDA
—
Shares Out
49.1M
Financials (TTM)
Revenue
$0
Net Income
-$3.0M
EBITDA
-$3.0M
Free Cash Flow
-$5.3M
Op Cash Flow
-$5.3M
EPS Basic
$-0.39
EPS Diluted
$-0.45
EPS Forward
$-99.00
Gross Margin
—
Op Margin
—
Net Margin
—
Balance Sheet
Total Assets
$17.6M
Total Liab.
$8.1M
Total Equity
$9.5M
Cash
$17.3M
LT Debt
$0
Book Value/Sh
$0.19
Debt/Equity
0.00x
Current Ratio
2.22
Quick Ratio
2.22
Returns & Growth
ROE
-20.2%
ROA
-10.9%
ROIC
-25.1%
Rev Growth YoY
+0.0%
EPS Growth YoY
+84.8%
Price Returns
2W
-4.0%
1M
-9.3%
3M
-11.2%
6M
-37.8%
12M
-65.2%
Technicals
52W High
$1.85
52W Low
$0.53
50d MA
$0.65
200d MA
$0.87
RSI (14)
47.20
ATR (14)
$0.04
Beta
2.18
Avg Volume
35K
Dividends
Div Rate
$0.01
Div Yield
0.7%
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
—
High
—
Low
—
Median
—
Data updated apr 25, 2026 8:48pm
· Source: financialmodelingprep.com